Literature DB >> 10025766

Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy.

K Iwatsuki, M Ohtsuka, H Akiba, F Kaneko.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10025766     DOI： 10.1016/s0190-9622(99)70210-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

1.  Anterior keratouveitis secondary to Hydroa vaccineforme: a role for ophthalmic slit-lamp examination in this condition?

Authors:  S Trikha; A Turnbull; N Srikantha; R Krishnan; A Tappin
Journal:  BMJ Case Rep       Date:  2011-04-13

2.  Ocular findings as a presenting sign of hydroa vacciniforme.

Authors:  B H Jeng; T P Margolis; N S Chandra; T H McCalmont
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  Clinicopathological analysis of the hydroa vacciniforme-like lymphoproliferative disorder with natural killer cell phenotype compared with cutaneous natural killer T-cell lymphoma.

Authors:  Guan-Nan Wang; Yong Cui; Wu-Gan Zhao; Ling Li; Xu-Dong Zhang; Yu Chang; Xian-Zheng Gao; Ye Li; Ming-Zhi Zhang; Wen-Cai Li
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

4.  Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Authors:  Anja Pahlow Mose; Niels Fisker; Ole Clemmensen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2014-11-24

5.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

Review 6.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07

7.  Hydroa vacciniforme-like cutaneous T-cell lymphoma.

Authors:  Jian-Qiang Shi; Qiu-Xia Chen; Shun-Fan Li; Wen Li
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.